Germinal Center Associated Signaling and Motility-like protein, known by the gene name GCSAML, is a relatively uncharacterized protein which is theorized to play a role in immune system function, particularly in the context of germinal center formation and activity. Germinal centers are specialized structures within secondary lymphoid organs where mature B lymphocytes proliferate, differentiate, and mutate their antibody genes during an immune response, leading to the production of high-affinity antibodies.The name GCSAML suggests a relationship to GCSAM, a protein implicated in the signaling and motility of B cells within germinal centers. If GCSAML functions similarly, it may be involved in regulating the signaling pathways that control B cell movement and interaction within lymphoid tissues, which is crucial for the proper formation and function of germinal centers. This could include roles in the dynamic rearrangement of cytoskeletal components which is necessary for B cell migration, as well as in the transduction of signals that regulate cell survival, proliferation, and differentiation.
Given the importance of germinal centers in the adaptive immune response, proteins like GCSAML could have significant impacts on the body's ability to mount effective defenses against pathogens. Anomalies in the function of such proteins might contribute to immunodeficiencies or immunopathologies, such as autoimmune diseases or lymphomas.Further research into GCSAML is needed to elucidate its exact biochemical functions and interactions with other proteins involved in germinal center dynamics. Understanding the role of GCSAML could provide valuable insights into the mechanisms governing B cell behavior in germinal centers and could identify new targets for intervention in immune-related conditions.
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
A potent inhibitor of PI3K, LY294002 blocks the PI3K/AKT signaling pathway, which is essential for cell survival and proliferation, potentially affecting GCASM-like. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
Wortmannin is a potent and irreversible PI3K inhibitor, impacting cellular processes like survival, differentiation, and motility that could indirectly affect GCASM-like. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $63.00 $241.00 | 136 | |
A selective inhibitor of MEK1/2, U0126 blocks the MAPK/ERK pathway, which may influence germinal center dynamics and indirectly modulate GCASM-like activity. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is a JNK inhibitor, potentially affecting transcription factor activity and inflammatory responses, indirectly impacting GCASM-like function. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
This compound inhibits p38 MAPK, involved in stress responses and cell differentiation, potentially altering GCASM-like associated processes. | ||||||
Ibrutinib | 936563-96-1 | sc-483194 | 10 mg | $153.00 | 5 | |
A Bruton's tyrosine kinase (BTK) inhibitor, ibrutinib may affect B cell receptor signaling, indirectly influencing GCASM-like. | ||||||
CAL-101 | 870281-82-6 | sc-364453 | 10 mg | $189.00 | 4 | |
Idelalisib selectively inhibits PI3Kδ, playing a critical role in adaptive immune responses, possibly affecting GCASM-like related pathways. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
An mTOR inhibitor, rapamycin can suppress cell growth and proliferation, potentially impacting signaling pathways relevant to GCASM-like. | ||||||
ABT-199 | 1257044-40-8 | sc-472284 sc-472284A sc-472284B sc-472284C sc-472284D | 1 mg 5 mg 10 mg 100 mg 3 g | $116.00 $330.00 $510.00 $816.00 $1632.00 | 10 | |
By inhibiting BCL-2, venetoclax promotes apoptosis in cancer cells, potentially affecting environments where GCASM-like is relevant. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
An ERK inhibitor, PD98059 may indirectly influence GCASM-like activity by modulating the MAPK signaling pathway. | ||||||